Evidence map›Paper›PMID 24713845›Full record

ReviewAnnals of gastroenterology2012

Systemic treatment-induced gastrointestinal toxicity: incidence, clinical presentation and management.

Stergios Boussios, George Pentheroudakis, Konstantinos Katsanos, Nicholas Pavlidis

Registry-linked trialAbstract readReview
In one paragraph

Review in Annals of gastroenterology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06560879 (Effectiveness of Probiotics for the Prevention of Gastrointestinal Toxicity and Changes in Gut Microbiota in Children With Acute Lymphoblastic Leukemia), which is not on this map. Cited by 116 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
116citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06560879 phase2enrolling by invitationnot on this mapstarted 2025, after this paper: background citation

Effectiveness of Probiotics for the Prevention of Gastrointestinal Toxicity and Changes in Gut Microbiota in Children With Acute Lymphoblastic Leukemia

TypeinterventionalSponsorNational Institute of Pediatrics, MexicoRan2025 to 2026Enrolled120ConditionsProbiotics, Gastrointestinal Diseases, Precursor Cell Lymphoblastic Leukemia-LymphomaArmsLactobacillus casei, Lactobacillus rhamnosus, Bifidobacterium bifidum, Placebo
3 · Its place in the literature

Who cites it

116 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

56 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Stergios BoussiosDepartment of Medical Oncology (Stergios Boussios, George Pentheroudakis, Nicholas Pavlidis).
George PentheroudakisDepartment of Medical Oncology (Stergios Boussios, George Pentheroudakis, Nicholas Pavlidis).
Konstantinos KatsanosFirst Department of Internal Medicine & Hepato-Gastroenterology Unit (Konstantinos Katsanos), Ioannina University Hospital, Ioannina, Greece.
Nicholas PavlidisDepartment of Medical Oncology (Stergios Boussios, George Pentheroudakis, Nicholas Pavlidis).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The toxicity of cancer chemotherapy is among the most important factors limiting its use. Clear delineation and communication of benefits and risks is an essential component of treatment decisions. Gastrointestinal toxicity during chemotherapy is frequent and contributes to dose reductions, delays and cessation of cancer treatment. The development of intervention strategies that could eliminate an expected side effect of chemotherapy is vital. Physiologic changes that can increase the toxicity of chemotherapy are decreased stem cell reserves, decreased ability to repair cell damage, progressive loss of body protein, and accumulation of body fat. Symptoms only arise when physiological functions are altered. The gastrointestinal symptoms arising during cancer chemotherapy can often be cured if newly acquired, and if gastrointestinal physiological deficits are identified. Developing new chemotherapy regimens with similar efficacy but less toxicity should be a priority for future research.

Indexed as

cancerchemotherapygastrointestinal toxicity

Identifiers

PMID24713845
PMCPMC3959393

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.